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Abstract Postmortem chemistry is becoming increasingly
essential in the forensic pathology routine and considerable
progress has been made over the past years. Biochemical
analyses of vitreous humor, cerebrospinal fluid, blood and
urine may provide significant information in determining
the cause of death or in elucidating forensic cases.
Postmortem chemistry may essentially contribute in the
determination of the cause of death when the pathophysi-
ological changes involved in the death process cannot be
detected by morphological methods (e.g. diabetes mellitus,
alcoholic ketoacidosis and electrolytic disorders). It can
also provide significant information and useful support in
other forensic situations, including anaphylaxis, hypother-
mia, sepsis and hormonal disturbances. In this article, we
present a review of the literature that covers this vast topic
and we report the results of our observations. We have
focused our attention on glucose metabolism, renal function
and electrolytic disorders.
Keywords Postmortem chemistry . Biochemical markers .
Glucose metabolism . Electrolytes . Renal function
Introduction
In 1993, Coe [1] published an article titled “Postmortem
Chemistry Update: Emphasis on Forensic Application”, in
which he reviewed postmortem chemistry and the articles
pertaining to this subject over the last 15 years. In his
introduction, Coe defined forensic chemistry as “one of the
more important ancillary procedures for the forensic
pathologist”. He also emphasized that routine examinations
of vitreous electrolytes, glucose and urea nitrogen alone
provided significant information in determining the cause
of death as well as assisting in determining the time of
death in more than 5% of all cases. Moreover, forensic
chemistry helped in solving forensic problems in about
10% of the routine, natural deaths.
Succeeding Coe, many other authors have approached
forensic chemistry bringing new points of views, ideas,
suggestions and solutions for improving sampling accuracy,
the choice of the analytical technique as well as measure-
ment precision. The number of substances that may be used
for diagnostic purposes in forensic routine has increased
significantly, though some studies have put back into
question the usefulness of other molecules that are no
longer systematically used. Postmortem determinations of a
wide variety of substances are now technically possible in
many biological fluids, including blood, vitreous humor,
urine, cerebrospinal, pericardial and synovial fluids [2–15].
A very important array of new material on postmortem
chemistry has appeared since Coe’s article; hence, forensic
chemistry today seems to be even more complementary to
the work of forensic pathologists.
The aim of these two articles is to propose a review of
the literature covering this vast topic, for which the
diagnostic potential is, in our opinion, still greatly unex-
plored. Unlike Coe, we have focused our attention on the
molecules with the potential of offering information
concerning the cause of death and did not expand upon
the analyses which, historically, have been used to
determine the time of death. Moreover, given that forensic
chemistry analyses are currently used in our medico-legal
centre, we have reported the results of our observations
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where possible. In the first part of this work, we concentrate
on glucose metabolism, renal function and electrolytes.
Glucose metabolism
Glucose, lactate and hyperglycaemia
In clinical practice, glycaemia and glycated haemoglobin
are the main biochemical markers for diagnosing disorders
in glucose metabolism. In forensic pathology, glycaemia is
of no value as a biochemical parameter due to substantial
fluctuations in glucose levels after death since glycolysis
continues spontaneously making blood glucose concentra-
tions fall extremely rapidly. Furthermore, death may be
preceded by agonal processes and cardiopulmonary resus-
citation, which are often associated with the secretion or the
administration of catecholamines. This results in further
mobilisation of liver glycogen and the release of glucose
into blood circulation as a counterbalancing phenomenon.
Considering the difficulty in interpreting postmortem blood
glucose levels, other biological fluids, such as vitreous
humor and cerebrospinal fluid, have been proposed in order
to estimate the antemortem blood glucose concentrations
[1, 12–29].
Respecting the assumption that glycolysis continues
spontaneously after death and that two molecules of lactic
acid are the final product of the postmortem glycolysis of
one molecule of glucose, Traub [30] proposed that
postmortem glycaemia could be estimated by combining
the values of glucose and lactate in cerebrospinal fluid.
After Traub, other authors have proposed the establishment
of the sum values of glucose and lactate in vitreous humor
or cerebrospinal fluid, to estimate the antemortem blood
glucose concentrations [31–36].
Karlovsek [37, 38] compared several biochemical param-
eters (glycated haemoglobin, glucose, lactate and combined
glucose and lactate values) in vitreous and cerebrospinal fluid
in 112 forensic cases divided into two diagnostic groups (41
diabetics and 71 control cases). The author proposed that
vitreous glucose levels over 13 mmol/l (corresponding
to 234 mg/dl) or combined glucose and lactate values in
vitreous or cerebrospinal fluid over threshold values of 23.7
(427 mg/dl) and 23.4 mmol/l (422 mg/dl) respectively could
indicate antemortem hyperglycaemia with a fatal outcome.
The supplementary determinations of glycated haemoglobin,
acetone and other ketone bodies were also recommended in
order to identify diabetic ketoacidosis.
Zilg et al. [39] evaluated the usefulness of the sum value
of glucose and lactate in vitreous. They applied a strategy
which included the consistent sampling of vitreous as soon
as possible upon arrival of the body at the morgue as well
as immediate bedside analysis using a blood gas instru-
ment. Three thousand seventy-six cases were included in
the study and the authors found that, after an initial drop of
vitreous glucose during the very early postmortem period,
the levels stayed stable for an appreciable amount of time
after death. The analysis of a second sample collected at
autopsy 1–3 days later showed similar results. In contrast,
the vitreous lactate levels showed a steady increase,
suggesting that the sum of glucose and lactate increased
with postmortem time. No case with a circumstantial
indication of hyperglycaemia showed only high vitreous
lactate. The authors suggested that vitreous glucose alone
should be employed to diagnose hyperglycaemia and
indicated the limit of 10 mmol/l (180 mg/dl), theoretically
corresponding to a blood glucose value of about 26
mmol/l (468 mg/dl). Regarding the methodology, they
concluded that sonication, centrifugation and the addition
of fluoride to the samples were unnecessary procedures
when a blood gas instrument was used.
In our medico-legal centre, we observed several cases
of diabetic ketoacidosis showing increased glucose levels
in vitreous and cerebrospinal fluid (over 20 mmol/l
in both fluids, corresponding to 360 mg/dl), glucose
in urine and increased blood acetone and 3-β-
hydroxybutyrate (3HB) values. There were no cases in
which only increased vitreous lactate was shown. Our
results confirmed the conclusions of Zilg et al. suggest-
ing that the combined values of glucose and lactate in
vitreous or cerebrospinal fluid do not add any further
information in estimating antemortem blood glucose
concentration. Vitreous glucose concentration is the most
reliable marker for this. Its determination, together with
the measurements of ketone bodies, urine glucose and
glycated haemoglobin, can easily confirm the existence
of a glucose metabolism disorder and a diabetic decom-
pensation as cause of death.
Glycated haemoglobin and vitreous fructosamine
Osuna et al. and Vivero et al. [36, 40, 41] compared several
biochemical parameters (fructosamine, glucose, lactate,
combined values of glucose and lactate) in vitreous, in
order to confirm the presence of antemortem hyperglycaemia
and to diagnose diabetes mellitus.
Goullé et al. [42] studied the stability of glycated
haemoglobin as a function of time in different samples
with or without anticoagulants and preservatives. A total of
106 tests were performed. Samples containing ethylenedia-
minetetraacetic acid (EDTA) and stored at 4°C were
indicated as optimal for blood conservation. The authors
confirmed the usefulness of glycated haemoglobin for
interpreting increased postmortem ketone body blood levels
and diagnosing diabetes mellitus decompensation as the
cause of death.
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Uemura et al. [8] investigated 11 clinically available
biochemical markers (including glycated haemoglobin,
fructosamine, urea nitrogen, creatinine, C-reactive protein,
total bilirubin, total protein and total cholesterol) in whole
blood (for glycated haemoglobin) and postmortem serum
(for the other markers) from three sampling sites (left
cardiac blood, right cardiac blood and femoral vein blood)
in 164 consecutive autopsy cases. Of all markers examined,
glycated haemoglobin showed the smallest deviation from
living subjects, negligible postmortem changes and no
difference due to the cause of death. On the contrary,
fructosamine showed a large deviation from living subjects.
According to the authors, these differences were related to
the nature of the marker: the level of glycation of
haemoglobin is a process the rate of which is determined
by the level of glucose concentration under the lifespan of
erythrocytes, whereas the other markers, including fructos-
amine, are components of tissues reflecting their destruction
or elimination from the blood by the organs.
Ketone bodies and diabetic ketoacidosis
Ketone bodies (acetoacetate (AcAc), 3HB and acetone), a
by-product of fat metabolism, are produced in the liver as
an alternative energy source when insufficient insulin is
available for effective glucose use. Ketogenesis is the
process by which fatty acids released from the adipocytes
are converted in AcAc and 3HB in the mitochondria of
hepatocytes. Ketosis is the term that refers to the
excessive presence of ketone bodies in blood; ketonuria
refers to the presence of ketone bodies in urine. Levels
of circulating ketone bodies vary across populations of
normal individuals, as a result of variations in basal
metabolic rate, hepatic glycogen stores and differences in
the mobilisation of amino acids from muscle proteins.
Most investigators agree that normal serum levels of ketone
bodies can be defined as being less than 500 μmol/l.
Hyperketonemia can be defined as levels in excess of
1,000 μmol/l and ketoacidosis as levels over 3,000 μmol/l.
Physiologic ketosis occurs when mildly to moderately
elevated levels of circulating ketone bodies are present in
response to fasting or prolonged exercise. Diabetic ketoaci-
dosis (DKA) is the most common pathologic cause of ketosis.
In patients with type 1 diabetes, ketosis occurring in
association with hyperglycaemia confirms the presence of
insulin deficiency. Other possible causes of ketosis are
alcoholic ketoacidosis, severe hypoxia, end-stage liver dis-
ease, hepatic ischemia, various metabolic disorders and
multiple organ failure [43–45].
Postmortem investigations of ketone bodies in blood and
other biological fluids have been performed by several
authors in order to diagnose ketoacidosis as the cause of
death [4, 33, 46–49].
In a study performed by Osuna et al. [47] on 453
forensic cases divided into two diagnostic groups (diabetics
and the control group), cases showing increased vitreous
glucose values over 200 mg/dl (11.1 mmol/l) also showed
the highest 3HB concentrations, confirming the usefulness
of determining vitreous 3HB concentrations as an alterna-
tive to blood.
Kanetake et al. [48] investigated levels of 3HB and
acetone in the postmortem serum of 100 forensic cases and
concluded that in cases without anatomical or toxicological
causes of death, the measurement of ketone body levels
could be informative. They also proposed that 3HB serum
levels over 1,000 μmol/l (10.4 mg/dl) could indicate
ketoacidosis as the cause of death in cases showing
physical conditions characterized by a tendency to increases
in ketone body concentrations.
In our medico-legal centre, several cases of diabetic
ketoacidosis showing high acetone values in blood, urine
and vitreous and high 3HB values in blood, urine, vitreous,
pericardial and cerebrospinal fluid were observed. Cases of
diabetic ketoacidosis usually showed blood 3HB concen-
trations over 6,000 μmol/l (62.5 mg/dl). Glucose levels in
vitreous and cerebrospinal fluid were usually over
20 mmol/l.
Isopropyl alcohol and ketoacidosis
The presence of isopropyl alcohol (IPA) in biological fluids
has been traditionally considered to indicate exposure to
this alcohol via oral ingestion or inhalation, as well as
postmortem production. However, IPA was observed in the
biological fluids of animals suffering from acetonemia,
suggesting that acetone could be metabolized to IPA by
alcohol dehydrogenase in certain disease states [50].
Nevertheless, the traditional interpretation of detectable
blood levels of IPAwas the exposure to the substance itself.
Bailey [50] identified five diabetic patients with ketosis
and detectable levels of IPA in blood. All patients had type
I diabetes mellitus and were insulin-dependent. According
to medical records, none of the patients had a history of IPA
exposure and all were hyperglycaemic upon admission.
Serum concentration of IPA ranged from 20 (332 μmol/l) to
297 mg/l (4,900 μmol/l) and serum concentration of
acetone ranged from 5.8 (1,000 μmol/l) to 32 mg/dl
(5,500 μmol/l). According to the author, these findings
corroborated those published by Davis et al. [51], who
postulated that acetone could be converted to IPA in
situations in which NADH was elevated.
In a study on acetonemia and other volatile alcohols
published by Teresinski et al. [52], the authors selected 75
forensic cases assigned to six groups (including hypother-
mia, fatal acetone and isopropyl alcohol intoxications and
sudden death in alcoholics). The authors found increased
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IPA concentrations not only in individuals intoxicated with
this agent, but also in the groups of hypothermia cases and
sudden death in alcoholics. The authors do not explain
these results, though they point out the hypothesis given by
Davis, Bailey and Jones and Summers [53] of an
endogenous transformation of acetone to IPA in certain
disease states as a possible explanation.
Jenkins et al. [54] and Molina [55] investigated the
concentrations of IPA in blood and vitreous. In a retrospec-
tive study carried out by Molina on 152 autopsy cases with
nine different IPA sources (including IPA exposure), the
author measured blood and vitreous IPA and acetone
concentrations and concluded that cases of IPA intoxica-
tions tended to have blood IPA values over 100 mg/dl and
IPA/acetone ratios more than 1.0.
In our medico-legal centre, IPA is systematically measured
in blood, urine and vitreous in cases of diabetes mellitus,
suspected hypothermia and death in alcoholics. A blood
concentration of 15 mg/l of IPA (249 μmol/l) was observed in
a case of hypothermia. In a case of diabetic ketoacidosis we
noted increased blood (57 mg/dl–9,800 μmol/l) and vitreous
acetone (91 mg/dl–15,650 μmol/l) values and a blood IPA
concentration of 50 mg/l–830 μmol/l (49 mg/l in vitreous–
813 μmol/l).
Ketone bodies, alcoholic ketoacidosis and alcoholic lactic
acidosis
The syndrome of a wide-gap metabolic acidosis, malnutri-
tion, and binge drinking superimposed on chronic alcohol
abuse is most commonly referred to as alcoholic ketoaci-
dosis [56–62]. The possible role of alcoholic ketoacidosis
as cause of death has been investigated by several authors
[35, 46–48, 63–66].
Thomsen et al. [64] proposed the term of “ketoalcoholic
death” for cases showing blood ketone body concentrations
over 531 μmol/l in alcoholics with an otherwise unknown
cause of death.
Pounder et al. [46] investigated levels of total ketone
bodies in postmortem samples including vitreous, pericar-
dial fluid and blood from different sampling sites. Vitreous
ketone body levels showed good correlation with blood and
pericardial fluid levels. According to the authors, increased
ketone body levels (over 10,000 μmol/l in blood and
5,000 μmol/l in vitreous) could be indicative of severe
alcoholic ketoacidosis.
Brinkmann et al. [35] investigated alcoholic ketoacidosis
and alcoholic lactic acidosis (caused by thiamine deficiency)
as causes of death in chronic alcoholics. In an initial series of
forensic cases investigated by the authors, blood acetone
levels ranged from 9.8 to 40 mg/dl (1,685 to 6,880 μmol/l) in
six cases with no cause of death at autopsy. The authors
suggested that blood acetone values over 9 mg/dl
(1,548 μmol/l) could indicate a fatal alcoholic ketoacidosis.
However, they emphasized the importance of 3HB as a more
accurate indicator of ketoacidosis. In a second series of
forensic cases investigated by the authors, the cause of death
was determined to be alcoholic lactic acidosis when three
criteria were met: glucose and lactate sum value in cerebro-
spinal fluid above 300 mg/dl (16.6 mmol/l), no indication of
diabetes from previous history, histology or glycated haemo-
globin determination and no cause of death even after
extensive toxicology.
Iten et al. [65] investigated blood concentrations of 3HB
in DKA and alcoholic acidosis and proposed that blood
3HB concentrations up to 500 μmol/l (5.2 mg/dl) can be
regarded as normal, from 500 to 2,500 μmol/l (26 mg/dl) as
high and over 2,500 μmol/l as pathological.
Elliott et al. [66] investigated the relationship between
3HB, acetone and ethanol in 350 medico-legal autopsy
cases and concluded that 3HB values over 25 mg/dl
(2,400 μmol/l) in blood (and to some extent in the urine)
could be considered pathologically significant. The authors
also concluded that 3HB in vitreous can be considered a
useful alternative when blood is absent, with the same
interpretative range.
In our medico-legal centre, we experienced some cases
of ketoacidosis in chronic alcohol abusers with no previous
diagnosis of diabetes mellitus and no cause of death on
autopsy and histology. All cases showed negative toxicol-
ogy, no ethanol in blood, undetectable glucose levels in
vitreous and cerebrospinal fluid and normal glycated
haemoglobin. Blood and vitreous 3HB concentrations
ranged from 1,650 (17.2 mg/dl) to 2,400 μmol/l (25 mg/dl).
We concluded that the cause of death was not clearly
identified but the increase of ketone bodies may have
represented a contributing factor in death.
Ketone bodies and hypothermia
Teresinski et al. [52, 67, 68] investigated ketone body blood
levels as biochemical markers of hypothermia and the
usefulness of ketone body determination in blood, urine and
vitreous for the diagnosis of death by hypothermia. They
started from the assumption that the cases of hypothermia
are usually accompanied by an increase in ketone bodies in
blood and urine and that the consumption of large amounts
of alcohol inhibits ketogenesis. Cases of suspected hypo-
thermia showed an inverse statistically significant relation-
ship between blood acetone and ethanol concentration. The
authors also emphasized that ketone body concentrations in
urine should be interpreted very cautiously, due to the
possible lack of ketonuria in conditions of coexisting
ketonemia and renal failure (shock aetiology) or in cases
of decreased ketonemia and persisting ketonuria (connected
to urine retention). Moreover, in case of rapidly increasing
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ketonemia, severity of ketosis cannot be evaluated solely on
the basis of vitreous analysis, since the equilibrium between
blood and vitreous requires some delay.
In our medico-legal centre, several cases of hypothermia
were observed in which the diagnosis was made on the
basis of the scene investigation data and autopsy findings
(frost erythema over the extensor surfaces of the large
joints, Wischnewski spots in the gastric mucosa and
haemorrhages in the iliopsoas muscles). The determination
of 3HB in blood, urine, vitreous, pericardial and cerebro-
spinal fluid was performed systematically. Also performed
systematically was the determination of ethanol, acetone
and isopropyl alcohol in blood, urine and vitreous, the
measurement of the glycated haemoglobin and the deter-
mination of glucose in vitreous and cerebrospinal fluid. Our
results support the hypothesis of Teresinski et al. that
suggest the existence of an inverse statistically significant
relationship between ketone body blood levels and ethanol
levels in cases of hypothermia.
Insulin and C peptide
Insulin is a peptide hormone secreted by the pancreatic β-
cells in response to hyperglycaemia. It is basal insulin
secretion that helps maintain normal fasting blood glucose,
while prandial insulin is secreted in response to increases in
glucose and nutrients at mealtimes. Another hormone
secreted by the pancreas, glucagon, is also involved in the
control of blood glucose levels. In fact, it is the opposing
actions of insulin and glucagon that help fine-tune glucose
homeostasis. In the presence of hyperglycemia, the pancre-
atic β-cells secrete more insulin, stimulating glucose
transport into muscle and adipocytes, and inhibiting glucose
production in the liver. These actions are counterbalanced
by those of glucagon (secreted by the pancreatic α-cells),
which is suppressed by hyperglycemia but stimulated
during hypoglycemia. Active insulin consists of two
peptides chains (A and B chains) that are linked by two
disulfide bridges. Before secretion, the proinsulin molecule
(inactive form) exists as a long chain with a connecting
peptide (C peptide) between the A and B chains. Enzymes
within the β-cell secretory granules cleave the C peptide
before secretion; therefore, when the stimulus for secretion
arrives, the granules release both active insulin and C
peptide. Analysis of insulin and C peptide are of forensic
interest in the investigation of unclear hypoglycaemia. Due
to different half-lives and clearance-rate, both peptides
reach their maximum concentration at different times after
meals. Both insulin and C peptide are secreted in equimolar
concentrations. However, since C peptide has the longer
half-life, the peptides are not always present in equimolar
amounts in the bloodstream, meaning that the ratio of
insulin to C peptide should be near 1.0 or even slightly
higher. Degradation of insulin is mainly the result of
glutathione insulin transhydrogenase in the liver, whereas
C peptide is removed from the circulation by the kidneys.
Less that 1% of intact human insulin is excreted into urine.
The ratio of insulin to C peptide in a living person is
thought to reliably distinguish hypoglycaemia due to
exogenous insulin (I/C>1) from hypoglycaemia due to an
insulinoma or sulfonylurea overdose (I/C<1). Insulin in
postmortem serum is extremely difficult to measure
accurately because it degrades rapidly at room temperature.
Peripheral blood sample has been indicated as the best
specimen for postmortem detection of insulin, because
heart blood, especially the heart-side heart blood, may
show concentrations higher than peripheral specimens.
Peripheral blood samples should be collected in tubes
containing sodium chloride or EDTA and postmortem
serum should be separated from the red blood cells as
soon as possible and then refrigerated or, preferably,
frozen. Measurement of C peptide is essential for the
accurate interpretation of insulin levels. C peptide is
more stable than insulin in postmortem blood. However,
collection and storage of specimens for C peptide
analyses require special handling: collection in hepari-
nised tubes, separation of postmortem serum and, without
delay, storage of the sample in a freezer [13, 69–72].
Several cases of insulin overdose, in diabetic and non
diabetic individuals, have been reported. Bile, vitreous and
postmortem serum from right heart blood were also used to
detect insulin. However, postmortem serum from peripheral
blood is the sample of choice. Tissue samples of liver, brain
or kidney are not recommended for insulin levels. An
elevated postmortem serum insulin level, along with a
suppressed C peptide level, is virtually diagnostic of an
exogenous insulin administration. If an injection site is
detected on the body, the excision of the surrounding
dermal area should be taken into consideration: toxicolog-
ical analysis and immunohistochemical demonstration of
insulin in the tissues at the injection site should always be
performed [73–91].
Insulin values in postmortem serum suggesting or
evocating lethal dosages are difficult to propose. Patel
[79] provided a table of insulin values for normal fasting
(5–75 μUI/ml—35–521 pmol/l) versus fatal insulin over-
dose (800–3,200 μIU/ml—556–22,224 pmol/l). Kernbach-
Wighton and Püschel [82] proposed the lower limit of
100 μUI/ml for lethal insulin dosage. Musshoff et al. [13]
reported that clearly elevated serum insulin levels could be
caused by intentional insulin overdose, because levels of
1,000 μUI/ml are rarely seen in patients with insulin-
secreting tumours. Karlovsek [37, 38] proposed a summary
of the biochemical indicators which would support the
hypothesis of hypoglycaemia at the time of death, including
low or indeterminate glucose concentration in vitreous
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immediately after death; extremely low glycated haemo-
globin in treated diabetics as a consequence of repeated
hypoglycaemic states and biochemical and toxicological
findings indicating insulin or anti-diabetic overdose.
In our medico-legal centre, two cases of insulin overdose
have been recently observed. In the first case, the
postmortem insulin serum level (from femoral blood) was
154 μIU/ml (1,070 pmol/l). In the second case, the
postmortem insulin serum level (from femoral blood) was
582 μIU/ml (4,041 pmol/l). In both cases, C peptide in
postmortem serum from femoral blood was under the
detection limit. Moreover, insulin was demonstrated immu-
nohistochemically in the subcutaneous tissue surrounding
the needle tracks. In the second case, insulin and C peptide
levels were measured in vitreous, cerebrospinal fluid, bile
and pericardial fluid. The results showed detectable levels
of insulin in all fluids, even in vitreous, where insulin is
thought to penetrate minimally. In order to test the
usefulness of postmortem insulin and C peptide determi-
nations, we measured their concentrations in postmortem
serum from femoral blood, pericardial fluid and vitreous in
20 control cases, with various causes of death. The results
confirmed that insulin and C peptide penetrate the blood-
vitreous barrier only minimally and to a greater extent in
the pericardial fluid.
Renal function
Urea nitrogen, creatinine and uric acid
Postmortem urea nitrogen and creatinine stability in
biological fluids have been tested by numerous authors.
Most of them concluded that urea nitrogen is a very stable
compound and that its levels in postmortem serum closely
approximate the antemortem serum levels, irrespective of
the methodology used, the level found and the duration of
postmortem interval, even after moderate decomposition
[1]. Studies performed on urea nitrogen in cerebrospinal
fluid showed a slight rise after death. In general, however,
postmortem values reflect the antemortem levels, as they do
in vitreous and even in the synovial fluid [1–3, 92]. In
addition to its importance in assessing renal function, mild
urea nitrogen increases, in association with hypernatremia,
can confirm antemortem dehydration, which generally
causes urea nitrogen levels to rise more than creatinine
levels. Similar to urea nitrogen, postmortem creatinine
levels remain stable in vitreous and cerebrospinal fluid [1].
Zhu et al. [93–95] analysed urea nitrogen, creatinine and
uric acid levels in pericardial fluid and postmortem serum
from different sampling sites (right heart, left heart,
subclavian vein and external iliac vein). In an initial study
performed on 395 medico-legal autopsy cases, the authors
found that a considerable elevation of uric acid, especially
in postmortem serum from right heart blood, was observed
in fatal mechanical asphyxiation and drowning, suggesting
that postmortem hyperuricemia in acute deaths could be
associated with hypoxic skeletal muscle damage following
hyperactivity or agonal convulsions. In a second study
performed on 409 medico-legal autopsy cases, the authors
compared urea nitrogen, creatinine and uric acid levels in
postmortem serum and pericardial fluid and emphasized
that, because of the nature of the pericardial fluid, in which
the turnover rates are much milder than those in blood,
elevations in pericardial urea nitrogen, creatinine and uric
acid suggested the existence of persistent metabolic
deteriorations before death. In a third study realized on
556 medico-legal autopsy cases, the authors compared the
differences between pericardial fluid and postmortem serum
levels of urea nitrogen, creatinine and uric acid and
concluded that since significant changes in pericardial fluid
levels became apparent some hours later than in the serum,
elevated urea nitrogen, creatinine and uric acid levels in
pericardial fluid could suggest prolonged survival of several
hours.
Maeda et al. [96] analysed urea nitrogen, creatinine and C-
reactive protein (CRP) postmortem serum levels in 429
medico-legal autopsy cases and found that fatal hyperthermia
cases showed elevated isolated creatinine levels (over 2 mg/
dl), without significant elevation of urea nitrogen and CRP.
Uemura et al. [8] investigated 11 clinically available
biochemical markers including urea nitrogen and creatinine
in postmortem serum from three sampling sites (left cardiac
blood, right cardiac blood and femoral vein blood) in 164
consecutive autopsy cases. The differences in the measured
values were classified according to sampling site and in
relation to postmortem interval and aetiology of death. For
urea nitrogen, no significant differences among the sam-
pling sites were found, whereas levels of creatinine were
lower in postmortem serum obtained from left cardiac
blood than from femoral blood. The authors concluded that
any sampling site could be used for urea nitrogen, whereas
postmortem serum obtained from left cardiac blood is
preferred for creatinine.
In our medico-legal centre, urea nitrogen and creatinine
are systematically measured in vitreous and in postmortem
serum, when available. Several cases of gastrointestinal
bleeding showing increased urea nitrogen levels in both
fluids with normal creatinine levels were observed. Cases
of dehydration usually showed increased postmortem serum
(from femoral blood) and vitreous urea nitrogen levels,
increased vitreous sodium and chloride levels and normal
postmortem serum and vitreous creatinine levels. In such
cases, in order to confirm the presence of prerenal failure,
the concentrations of urea nitrogen, creatinine and uric acid
were also measured in urine and the fractional excretion of
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urea was calculated. Cases of diabetic ketoacidosis showed
increased postmortem serum and vitreous urea nitrogen
levels, usually with normal postmortem serum and vitreous
creatinine levels.
Electrolytes
Byramji et al. [97] and Ingham and Byard [98] reviewed
the literature concerning electrolytes in vitreous and
particularly vitreous sodium. Electrolyte levels in vitreous
change after death, the degree of change depending on the
conditions of body storage, postmortem interval, sample
and analyte. Changes depend on the effects of cellular
hypoxia, which lead to increased cell membrane and blood
vessel wall permeability as well as a reduction in ATP
stores, which prevent electrolyte pumps from maintaining
physiological cell membrane electrical gradients. These
factors result in the merging of intra- and extracellular fluid
and their respective electrolytes which, coupled with
autolysis and cell disintegration, lead to important and
unpredictable changes in electrolyte contents in postmortem
samples. Vitreous sodium levels have been determined to
be relatively stable during the early postmortem period and
similar to levels found in the serum in living subjects.
According to several authors abnormalities in antemortem
serum sodium concentrations are reflected in postmortem
vitreous values, making it possible to diagnose hypo- or
hypernatremia at the time of death. Like sodium, vitreous
chloride concentrations show minimal falls in values during
the early postmortem period and abnormalities in antemortem
serum chloride are reflected in postmortem vitreous values
[1, 4, 6, 9, 19, 21–28, 97–99].
Cases of hypernatremia showing vitreous sodium con-
centrations ranging from 155 to 210 mmol/l and chloride
concentrations ranging from 139 to 147 mmol/l have been
reported in the literature [1, 100–102]. Madea and
Lachenmeier [103] mentioned 17 cases of hypertonic
dehydration showing increased vitreous sodium and urea
values. The authors also cited seven cases of increased
vitreous sodium values not related to dehydration and
concluded that prudence should be used in determining the
cause of death on the basis of vitreous sodium and chloride
values only.
Unnatural cases of hyponatremia upon autopsy [97,
104–113] include water intoxication from psychogenic
polydipsia, environmental polydipsia, ingestion of dilute
infant formulas, beer potomania, endurance exercise, fresh
water immersion and iatrogenic causes including drug and
parenteral fluid administration and surgical irrigation. If
antemortem findings are not available, vitreous sodium
levels lower than 120 mmol/l could support the diagnosis of
fatal hyponatremia [104].Ta
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Vitreous potassium levels [1] are of no help in
determining the potassium status of an individual immedi-
ately prior to death. Increased vitreous potassium levels
have no diagnostic value, whereas low vitreous levels are
theoretically indicative of hypokalemia.
Zhu et al. and Li et al. [114, 115] analysed postmortem
calcium (Ca) and magnesium (Mg) levels in pericardial
fluid and postmortem serum from different sampling sites
(right heart, left heart, subclavian vein and external iliac
vein). In a study performed on 360 medico-legal autopsy
cases, Zhu et al. [114] found that both Ca and Mg levels in
postmortem serum from cardiac and peripheral blood were
significantly higher in saltwater drownings. Moreover, a
significant elevation in postmortem serum from the left
cardiac blood of both markers compared with other
sampling sites suggested the influence of saltwater aspira-
tion. Freshwater drowning and fire fatalities showed
increased Ca postmortem serum levels, especially in
postmortem serum from peripheral blood, suggesting an
increase of skeletal muscle origin. In a study performed on
385 medico-legal autopsy cases, Li et al. [115] analysed
postmortem Ca and Mg levels in pericardial fluid. They
found that pericardial Ca levels were similar to clinical
serum reference range, whereas pericardial Mg levels were
generally higher. Both Ca and Mg levels were significantly
higher in saltwater drowning, suggesting the influence of
saltwater aspiration, whereas pericardial Ca were relatively
high for hypothermia cases.
Studies on the diagnostic value of strontium (Sr) in
seawater and freshwater drowning cases have been
performed by Azparren et al. [116–121], who measured Sr
concentrations in left and right ventricular blood, and by
Pérez-Cárceles et al. [122], who measured Sr concentra-
tions in postmortem serum from left and right ventricular
blood as well as femoral vein blood. These authors
confirmed the usefulness of cardiac blood (or postmortem
serum from cardiac blood) Sr levels in diagnosing seawater
and freshwater drownings, together with circumstantial data
and morphological findings, especially in cases which have
been in the water for less than 72 h [116–123].
In our medico-legal centre, vitreous sodium and chloride
are systematically measured. In a series of 473 medico-legal
autopsy cases, vitreous sodium averaged 136 mmol/l and
vitreous chloride 125 mmol/l. No case of fatal hypernatremia
was experienced in the last years in our centre, whereas cases
of alcohol abusers with advanced liver cirrhosis and other
signs of hepatic insufficiency (jaundice, ascites, pleural
effusion, recanalisation of umbilical vein, spleenomegaly
and pelvic and oesophagus varices) also showing increased
blood acetone and 3HB values and decreased vitreous sodium
and chloride levels, were sometimes observed. Since hypo-
natremia is a common problem in individuals with advanced
cirrhosis, directly related to the hemodynamic changes and
secondary neurohumoral adaptations, we concluded that, even
if the cause of death was not clearly identified, ketoacidosis
and hyponatremia may have represented a contributing factor
in death (Table 1).
Conclusions
It seems more and more evident that, in the past, the aim of
postmortem chemistry was almost exclusively to determine
“the cause of death”, to characterize “the metabolic profile”
consistent with a metabolic disorder, with or without
morphological findings, which could explain the death.
Cases of diabetic coma with a fatal outcome and presenting
pathologically increased vitreous glucose, glycated haemo-
globin and ketone body levels or insulin overdoses showing
pathologically increased insulin levels and suppressed C
peptide concentrations represent two examples of this
approach. However, many researchers have recently fo-
cused their attention on other possible approaches, with
different objectives. Today, postmortem chemistry can be
employed not only to determine the cause of death, but also
(and especially) to help in interpreting the cause of death
and to support and enforce morphological and toxicological
findings. On the one hand, it must be emphasized that
postmortem chemistry should be incorporated among the
routine forensic and medico-legal investigations, like
radiology, histology and toxicology, to improve the quality
of forensic autopsies. On the other hand, it must be stressed
that the interpretation of postmortem chemistry results
always requires prudence. Postmortem chemistry is of no
value without history, radiological investigations, macro-
scopic findings, histology and toxicology. However, and
with respect to this, it can undoubtedly represent one of the
most important ancillary procedures for the forensic
pathologist in investigating the cause and the process of
death, the contributing conditions and the predisposing
disorders.
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